Ocular Physiology

0
Pipeline Programs
1
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
TEST LENSN/A5 trials
Active Trials
NCT06778057Completed22Est. Oct 2025
NCT05530889Withdrawn0Est. May 2024
NCT05502289Completed66Est. Oct 2022
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS
Johnson & JohnsonTEST LENS

Clinical Trials (8)

Total enrollment: 610 patients across 8 trials

Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact Lenses

Start: Dec 2024Est. completion: Oct 202522 patients
N/ACompleted

Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies

Start: Jan 2024Est. completion: May 20240
N/AWithdrawn

Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

Start: Aug 2022Est. completion: Oct 202266 patients
N/ACompleted

Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process

Start: Jul 2022Est. completion: Sep 202266 patients
N/ACompleted

Evaluation of Rotation With a Multifocal Toric Contact Lens

Start: Jun 2022Est. completion: Jul 2022102 patients
N/ACompleted

Impact of Soft Contact Lenses on Lid-Parallel Conjunctival Folds

Start: Apr 2013Est. completion: Dec 201330 patients
N/ACompleted

Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)

Start: Apr 2008Est. completion: May 2010174 patients
N/ACompleted

Controlling Myopia Progression With Soft Contact Lenses

Start: Apr 2007Est. completion: Feb 2010150 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space